Filing Flows › Comparisons › BDPT vs TLPH
Bioadaptives vs Talphera: BDPT and TLPH compared
Bioadaptives is the larger company: $5K of revenue in its latest quarter (Q2 2026) against $1K for Talphera (Q3 2025).
Where the money goes: BDPT and TLPH
Bioadaptives (BDPT) · Q2 2026
Bioadaptives, Q2 2026: revenue $5K (+55% year over year), net earnings $150K, operating cash flow −$44K. The chart follows the revenue to costs, profit and cash.
Talphera (TLPH) · Q3 2025
Talphera, Q3 2025: revenue $1K, net loss $4.4M, operating cash flow −$2.5M. The chart follows the revenue to costs, profit and cash.
| Bioadaptives (BDPT) | Talphera (TLPH) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2025 |
| Revenue | $5K | $1K |
| Revenue growth, Y/Y | +55% | — |
| Operating margin | n/m | n/m |
| Net earnings | $150K | −$4.4M |
| Operating cash flow | −$44K | −$2.5M |
Questions
Which is bigger, Bioadaptives or Talphera?
Bioadaptives is the larger company: $5K of revenue in its latest quarter (Q2 2026) against $1K for Talphera (Q3 2025).
More: Bioadaptives earnings · how Bioadaptives makes money · Talphera earnings · how Talphera makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 19, 2026; 10-Q filed Nov 12, 2025). Fiscal quarters can end on different dates. Not investment advice.